Worldwide, seven drugs have been registered for the treatment of chronic hepatitis B. These include two interferons (conventional interferon and peginterferon alfa-2a) and five oral NAs (lamivudine, ...
Hepatitis doesn’t always announce itself. While hepatitis A often comes on abruptly, as with a bad stomach bug, most cases of ...
[Asia Economy Reporter Lee Gwan-joo] A study has attracted attention by showing that an oral chronic hepatitis B treatment drug is effective for non-alcoholic fatty liver disease (NAFLD), which ...
In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B. Subscribe to our ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
BOSTON (Reuters) - The chief executive of Idenix Pharmaceuticals Inc. on Tuesday said the potential demand for hepatitis B treatments in the United States and Europe is being underestimated, and that ...
Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...
Pharmaceutical Technology on MSN
Mirum to buy Bluejay for up to $820m in rare liver disease push
The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.
Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results